View Filter All NewsPress Release Years All Years2022202120202019201820172016201520142013201220112010 Apply Press Release | May 02, 2022 Vertex Provides Updates on Phase 1/2 Clinical Trial of VX-880 for the Treatment of Type 1 Diabetes READ MORE Press Release | April 21, 2022 Vertex to Announce First Quarter 2022 Financial Results on May 5 READ MORE Press Release | April 20, 2022 Health Canada Grants Marketing Authorization for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Children With Cystic Fibrosis Ages 6 Through 11 years With At Least One F508del Mutation READ MORE Press Release | March 31, 2022 Vertex Announces Statistically Significant and Clinically Meaningful Results From Two Phase 2 Proof-of-Concept Studies of VX-548 for the Treatment of Acute Pain READ MORE Pagination First page First Previous page Previous Page 1 Current page 2 Page 3 Next page Next
